Indonesia’s markets regulator has fined seven listed companies and several related parties a total of Rp 6.39 billion for breaches ranging from affiliate transactions to questionable asset reporting, underscoring the cost of weak disclosure and compliance at a time when investors are demanding cleaner governance from issuers.
Indonesia OJK Fines ADHI, KLBF, WMUU, 4 Others
The sanctions, announced by the Financial Services Authority, or OJK, hit state-controlled contractor Adhi Karya, drugmaker Kalbe Farma and poultry producer Widodo Makmur Unggas, alongside Asri Karya Lestari, Adhi Commuter Properti, Enseval Putera Megatrading and Limas Indonesia Makmur. While the cash amounts are small relative to market capitalisation, the action matters because it points to recurring weaknesses in related-party controls, financial reporting and audit discipline — areas that can affect earnings quality, funding access and valuation.
ASLI took the heaviest hit, with two fines of Rp 1.35 billion each after OJK said it could not rely on the value and supporting documentation for material assets recorded in interim and annual financial statements through 2025. The regulator also fined its directors jointly and severally Rp 645 million and penalised its external auditor Rp 107.5 million for lapses in audit procedures. For investors, that combination is more damaging than the absolute penalty: it raises questions about balance-sheet reliability, asset recognition and the credibility of reported numbers.
ADHI was fined Rp 450 million for failing to follow affiliate-transaction procedures on a shareholder loan agreement with unit ADCP, which was fined the same amount. OJK also sanctioned two appraisers linked to the deal. That is relevant because shareholder loans and other related-party arrangements are often used to support subsidiaries or stressed units, but they can also obscure the real transfer of risk within a group if approvals and fairness opinions are not handled properly.
KLBF was also sanctioned, along with distributor and peer EPMT, over a related-party asset transaction between Hale International and Forsta Kalmedic Global. The fines are modest for a blue-chip healthcare name, but for the market they reinforce a broader theme: even large, liquid issuers are not immune to compliance lapses, and repeated governance issues can weigh on the premium investors are willing to pay for consistency and transparency.
WMUU’s Rp 925 million fine is the largest single company-level penalty in the group after ASLI, tied to its failure to follow material-transaction procedures on a loan that was also deemed affiliated. That is significant in a sector already under margin pressure and financing strain, because debt-related transactions can become more sensitive when balance-sheet flexibility is limited.
LMAS received a written warning for failing to hold annual shareholder meetings for four consecutive financial years, while its directors were separately fined Rp 712.5 million. The case adds to the message from OJK’s latest enforcement round: governance breaches are not being treated as paperwork issues, but as compliance failures that can carry financial and reputational costs.
For investors, the immediate market impact is likely to be limited given the size of the penalties, but the wider implication is more durable. Governance risk can influence borrowing costs, auditor scrutiny, access to capital and the discount rates applied to Indonesian equities. Companies with cleaner disclosure and stronger internal controls may benefit if the market increasingly differentiates between compliant issuers and those repeatedly drawn into regulatory action.
The next catalyst is whether OJK follows this round with closer scrutiny of restatements, related-party dealings and audit quality. If it does, the long-term winners are likely to be issuers with stronger controls and transparent reporting, while companies with recurring compliance lapses may face a persistent valuation drag.
| Entity | Gains | Losses |
|---|---|---|
| OJK / regulators | ▲Stronger enforcement credibility | ▼None |
| Compliant issuers | ▲Wider governance premium | ▼Less room for lax practices |
| ADHI, KLBF, WMUU and peers | ▲Limited near-term benefit | ▼Fines, scrutiny, valuation risk |
| Investors | ▲Better disclosure standards | ▼Higher compliance uncertainty |

